These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10064576)

  • 1. Aldehyde oxidase-dependent marked species difference in hepatic metabolism of the sedative-hypnotic, zaleplon, between monkeys and rats.
    Kawashima K; Hosoi K; Naruke T; Shiba T; Kitamura M; Watabe T
    Drug Metab Dispos; 1999 Mar; 27(3):422-8. PubMed ID: 10064576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of human metabolism of the sedative-hypnotic zaleplon using chimeric mice transplanted with human hepatocytes.
    Tanoue C; Sugihara K; Uramaru N; Tayama Y; Watanabe Y; Horie T; Ohta S; Kitamura S
    Xenobiotica; 2013 Nov; 43(11):956-62. PubMed ID: 23651075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase.
    Lake BG; Ball SE; Kao J; Renwick AB; Price RJ; Scatina JA
    Xenobiotica; 2002 Oct; 32(10):835-47. PubMed ID: 12419014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain difference of oxidative metabolism of the sedative-hypnotic zaleplon by aldehyde oxidase and cytochrome P450 in vivo and in vitro in rats.
    Tanoue C; Sugihara K; Uramaru N; Watanabe Y; Tayama Y; Ohta S; Kitamura S
    Drug Metab Pharmacokinet; 2013; 28(3):269-73. PubMed ID: 23358259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of Zaleplon 5-Oxidase Activity in Mice and Humans, and Inhibition by Raloxifene.
    Tanoue C; Sugihara K; Tayama Y; Uramaru N; Watanabe Y; Ohta S; Kitamura S
    Drug Metab Lett; 2017; 10(4):278-285. PubMed ID: 28029084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of zaleplon metabolism by cimetidine in the human liver: in vitro studies with subcellular fractions and precision-cut liver slices.
    Renwick AB; Ball SE; Tredger JM; Price RJ; Walters DG; Kao J; Scatina JA; Lake BG
    Xenobiotica; 2002 Oct; 32(10):849-62. PubMed ID: 12419015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide.
    Sugihara K; Kitamura S; Tatsumi K
    Drug Metab Dispos; 1996 Feb; 24(2):199-202. PubMed ID: 8742231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate.
    Tan WK; Tan ARY; Sivanandam P; Goh EJH; Yap ZP; Saburulla NF; Austin-Muttitt K; Mullins JGL; Lau AJ
    J Pharmacol Exp Ther; 2020 Aug; 374(2):295-307. PubMed ID: 32393528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver.
    Rashidi MR; Smith JA; Clarke SE; Beedham C
    Drug Metab Dispos; 1997 Jul; 25(7):805-13. PubMed ID: 9224775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase.
    Austin NE; Baldwin SJ; Cutler L; Deeks N; Kelly PJ; Nash M; Shardlow CE; Stemp G; Thewlis K; Ayrton A; Jeffrey P
    Xenobiotica; 2001; 31(8-9):677-86. PubMed ID: 11569533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia.
    Heydorn WE
    Expert Opin Investig Drugs; 2000 Apr; 9(4):841-58. PubMed ID: 11060714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative metabolic pathway of lenvatinib mediated by aldehyde oxidase.
    Inoue K; Mizuo H; Kawaguchi S; Fukuda K; Kusano K; Yoshimura T
    Drug Metab Dispos; 2014 Aug; 42(8):1326-33. PubMed ID: 24914245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species differences in enantioselective 2-oxidations of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase.
    Itoh K; Yamamura M; Takasaki W; Sasaki T; Masubuchi A; Tanaka Y
    Biopharm Drug Dispos; 2006 Apr; 27(3):133-9. PubMed ID: 16400710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cynomolgus monkey liver aldehyde oxidase: extremely high oxidase activity and an attempt at purification.
    Sugihara K; Katsuma Y; Kitamura S; Ohta S; Fujitani M; Shintani H
    Comp Biochem Physiol C Toxicol Pharmacol; 2000 May; 126(1):53-60. PubMed ID: 11048665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation.
    Rodrigues AD; Kukulka MJ; Ferrero JL; Cashman JR
    Drug Metab Dispos; 1995 Oct; 23(10):1143-52. PubMed ID: 8654204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
    Strelevitz TJ; Orozco CC; Obach RS
    Drug Metab Dispos; 2012 Jul; 40(7):1441-8. PubMed ID: 22522748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
    Rodrigues AD; Ferrero JL; Amann MT; Rotert GA; Cepa SP; Surber BW; Machinist JM; Tich NR; Sullivan JP; Garvey DS
    Drug Metab Dispos; 1994; 22(5):788-98. PubMed ID: 7530622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extremely high drug-reductase activity based on aldehyde oxidase in monkey liver.
    Kitamura S; Ohashi KNK ; Sugihara K; Hosokawa R; Akagawa Y; Ohta S
    Biol Pharm Bull; 2001 Jul; 24(7):856-9. PubMed ID: 11456132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of brimonidine metabolism with rat, rabbit, dog, monkey and human liver fractions and rabbit liver aldehyde oxidase.
    Acheampong AA; Chien DS; Lam S; Vekich S; Breau A; Usansky J; Harcourt D; Munk SA; Nguyen H; Garst M; Tang-Liu D
    Xenobiotica; 1996 Oct; 26(10):1035-55. PubMed ID: 8905918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications.
    Diamond S; Boer J; Maduskuie TP; Falahatpisheh N; Li Y; Yeleswaram S
    Drug Metab Dispos; 2010 Aug; 38(8):1277-85. PubMed ID: 20421447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.